Reaction

Infusion Site Induration reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,403 reports · 55 co-occurring drugs

As of the last recalculation, Infusion Site Induration appears in 1,403 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 142.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Treprostinil	651	142.7	143.5
Ketoprofen	112	137.5	138.7
Amitriptyline Hydrochloride	99	90.0	90.5
Sildenafil Powder,	100	44.8	44.9
Macitentan	181	44.4	44.5
0Xygen	129	42.7	42.8
Oxygen	129	42.7	42.8
Sildenafil	144	41.0	41.1
Riociguat	84	40.6	40.7
Lidocaine Hydrochloride	145	39.7	39.8
Tadalafil	207	35.8	35.9
Rotigotine	34	35.7	35.8
Clonidine	111	34.8	34.9
Human Immunoglobulin G	42	31.1	31.2
Sodium Chloride Tablet	133	29.5	29.6
Sodium Chloride Tablets	133	29.5	29.6
Sodium Chloride	134	27.7	27.8
Sildenafil Citrate	204	27.6	27.7
Cetirizine Hcl	15	24.5	24.6
Ambrisentan	172	23.2	23.2
Selexipag	37	21.8	21.8
Diphenhydramine Hydrochloride Capsule, Liquid Filled	26	18.4	18.4
Torsemide	35	16.1	16.1
Metolazone	12	16.0	16.0
Hydroxyzine Hydrochloride	14	15.9	16.0
Hydroxyzine Hydrochloride Oral	14	15.9	16.0
Adrenalinum	40	14.7	14.7
Bosentan	47	14.3	14.3
Lidocaine	53	14.0	14.0
Bendamustine Hydrochloride	11	13.7	13.7
Buspirone Hydrochloride	10	13.5	13.5
Cyclobenzaprine Hydrochloride	8	13.3	13.3
Butalbital, Acetaminophen, And Caffeine	9	12.6	12.6
Bumetanide	22	12.5	12.5
Fluticasone Propionate Nasal	25	12.4	12.5
Lidocaine, Menthol	40	12.3	12.3
Epinephrine	52	12.2	12.2
Diphenhydramine	50	12.1	12.1
Lidicaine	39	12.1	12.1
Burn Relief	39	12.1	12.1
Lidocaine Hydrochloride And Epinephrine	39	12.1	12.1
Rasagiline Mesylate	9	12.1	12.1
Levodopa	9	11.1	11.1
Azelastine	13	10.8	10.8
Ropinirole	11	10.7	10.7
Fulvestrant	23	10.5	10.5
Rivastigmine	12	9.5	9.5
Levocetirizine Dihydrochloride	14	8.7	8.7
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	12	8.7	8.7
Naproxen Sodium, Pseudoephedrine Hydrochloride	12	8.7	8.7
Carbidopa And Levodopa	19	6.0	6.0
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	14	5.1	5.1
Carfilzomib	8	4.2	4.2
Rimegepant Sulfate	3	3.5	3.5
Droxidopa	3	2.1	2.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.